Hip, Knee Sales Growth Slows In Second Quarter For Top Orthopedic Firms
This article was originally published in The Gray Sheet
Executive Summary
Overall weakness in the hip-and-knee market resulted in low-single-digit reconstructive sales growth for Zimmer, Stryker and Johnson & Johnson/DePuy in the second quarter
You may also be interested in...
New Products In Brief
Xience/Promus approved for small vessels
New Products In Brief
Xience/Promus approved for small vessels
ConforMIS Begins Limited Release Of Patient-Specific Knee
ConforMIS is pursuing a limited release of its iTotal CR patient-specific total knee replacement system to get detailed feedback from surgeons on the implant procedure, which the company says involves fewer steps than with standard total knee implants. ConforMIS announced receipt of 510(k) clearance Feb. 3.